Reply to Theilacker et al

Clin Infect Dis. 2018 May 2;66(10):1642-1643. doi: 10.1093/cid/cix1115.

Pontus Naucler^{1

2}, Ilias Galanis³, Eva Morfeldt³, Jessica Darenberg³, Åke Örtqvist^{1

4}, Birgitta Henriques-Normark^{3

5

6

7}

¹ Unit of Infectious Diseases, Department of Medicine Solna, Karolinska Institutet, Stockholm.
² Department of Infectious Diseases, Karolinska University Hospital, Stockholm.
³ Public Health Agency of Sweden, Solna, Singapore, Singapore.
⁴ Department of Communicable Disease Control and Prevention, Stockholm County Council, Singapore, Singapore.
⁵ Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Singapore, Singapore.
⁶ Department of Clinical Microbiology, Karolinska University Hospital, Stockholm, Sweden, Singapore, Singapore.
⁷ Singapore Centre on Environmental Life Sciences Engineering (SCELSE) and Lee Kong Chian School of Medicine (LKC), Nanyang Technological University (NTU), Singapore, Singapore.

No abstract available

Publication types